Evidence map›Paper›PMID 33884753›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2021

Reduced synchrony in alpha oscillations during life predicts post mortem neurofibrillary tangle density in early-onset and atypical Alzheimer's disease.

Kamalini G Ranasinghe, Cathrine Petersen, Kiwamu Kudo, Danielle Mizuiri, Katherine P Rankin, Gil D Rabinovici, Maria Luisa Gorno-Tempini, William W Seeley, Salvatore Spina, Bruce L Miller and 3 more

Open access · greenAbstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Tracking electrophysiological signatures of Alzheimer's disease: a systematic review of multimodal studies.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Neurophysiological trajectories in Alzheimer's disease progression.bioRxiv : the preprint server for biology · 2024
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Does Alzheimer's disease with mesial temporal lobe epilepsy represent a distinct disease subtype?Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023
    Article
  20. Connectome-based biophysics models of Alzheimer's disease diagnosis and prognosis.Translational research : the journal of laboratory and clinical medicine · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Kamalini G RanasingheMemory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, California, USA.
Cathrine PetersenMemory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, California, USA.
Kiwamu KudoDepartment Radiology & Biomedical Imaging, University of California San Francisco, San Francisco, California, USA.
Danielle MizuiriDepartment Radiology & Biomedical Imaging, University of California San Francisco, San Francisco, California, USA.
Katherine P RankinMemory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, California, USA.
Gil D RabinoviciMemory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, California, USA.
Maria Luisa Gorno-TempiniMemory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, California, USA.
William W SeeleyMemory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, California, USA.
Salvatore SpinaMemory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, California, USA.
Bruce L MillerMemory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, California, USA.
Keith VosselMemory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, California, USA.
Lea T GrinbergMemory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, California, USA.
Srikantan S NagarajanDepartment Radiology & Biomedical Imaging, University of California San Francisco, San Francisco, California, USA.
University Memory and Aging Center · USUniversity of California System · USUniversity of California, San Francisco · USUniversidade de São Paulo · BR

Funding

Early Onset AD Consortium - the LEAD Study (LEADS)U01AG057195 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · PI APOSTOLOVA, LIANA G, CARRILLO, MARIA C · 2018 to 2023
$70.3M
TDP-43 Loss-of-Function: Biology to BiomarkersP01AG019724 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Jennifer Merrilees · 2002 to 2026
$67.2M
Research Education ComponentP30AG062422 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Gil Dan Rabinovici · 2019 to 2026
$36.9M
PrPSc SPECIFIC INTERACTION WITH NOVEL PrP-Fc FUSION PROTEINSP50AG023501 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HUANG, YADONG · 2004 to 2018
$27.1M
Clinical Features and Neuropathological Basis of Sleep Wake Behavior in Alzheimer's and PSPR01AG060477 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Lea Tenenholz Grinberg, Thomas C Neylan · 2019 to 2026
$8.2M
Linking Sleep Dysfunction to Tau-related Degeneration across AD ProgressionR01AG064314 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRINBERG, LEA TENENHOLZ, NEYLAN, THOMAS C · 2019 to 2023
$4.0M
Dynamic Brain Imaging of Speech in Primary Progressive AphasiaR01NS100440 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARIA LUISA GORNO TEMPINI, John Francis Houde · 2017 to 2026
$3.6M
Imaging brain iron and protein aggregation with MRI for assessing Alzheimer's disease pathology and progressionR01AG070826 · NIA · UNIVERSITY OF CALIFORNIA BERKELEY · PI GRINBERG, LEA TENENHOLZ, LIU, CHUNLEI · 2021 to 2025
$3.3M
Network Modelling of Multimodal Dynamics in Alzheimer’s Disease and DementiaRF1AG062196 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI NAGARAJAN, SRIKANTAN S., RAJ, ASHISH · 2019 to 2019
$3.0M
Training program in the neurology of language and neurodegenerative aphasiasK24DC015544 · NIDCD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GORNO TEMPINI, MARIA LUISA · 2016 to 2025
$1.9M
Neuropathological changes underlying clinical heterogeneity in Alzheimer diseaseK24AG053435 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRINBERG, LEA TENENHOLZ · 2016 to 2025
$1.8M
Imaging sensorimotor adaptation and compensation of speechR01DC013979 · NIDCD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HOUDE, JOHN FRANCIS, NAGARAJAN, SRIKANTAN S. · 2014 to 2018
$1.7M
NIA NIH HHS F32 AG050434NIA NIH HHS K08 AG058749NIA NIH HHS K23 AG038357NIA NIH HHS K24 AG053435NIA NIH HHS P01 AG019724NIA NIH HHS P30 AG062422NIA NIH HHS P50 AG023501NIA NIH HHS R01 AG060477NIA NIH HHS R01 AG064314NIA NIH HHS R01 AG070826NIA NIH HHS RF1 AG062196NIA NIH HHS U01 AG057195NIBIB NIH HHS R01 EB022717NIDCD NIH HHS K24 DC015544NIDCD NIH HHS R01 DC013979NIH HHS UCOP MRIP MRP-17-454755 (SSN)NINDS NIH HHS R01 NS100440
6 · The paper itself

Abstract

introductionNeurophysiological manifestations selectively associated with amyloid beta and tau depositions in Alzheimer's disease (AD) are useful network biomarkers to identify peptide specific pathological processes. The objective of this study was to validate the associations between reduced neuronal synchrony within alpha oscillations and neurofibrillary tangle (NFT) density in autopsy examination, in patients with AD.

methodsIn a well-characterized clinicopathological cohort of AD patients (n = 13), we quantified neuronal synchrony within alpha (8-12 Hz) and delta-theta (2-8 Hz) oscillations, using magnetoencephalography during the disease course, within six selected neocortical and hippocampal regions, including angular gyrus, superior temporal gurus, middle frontal gyrus, primary motor cortex, CA1, and subiculum, and correlated these with regional NFT density quantified at histopathological examination.

resultsAbnormal synchrony in alpha, but not in delta-theta, significantly predicted the NFT density at post mortem neuropathological examination. DISCUSSION: Reduced alpha synchrony is a sensitive neurophysiological index associated with pathological tau, and a potential network biomarker for clinical trials, to gauge the extent of network dysfunction and the degree of rescue in treatments targeting tau pathways in AD.

Indexed as

AutopsyNeuropathologyAgedAlzheimer DiseaseAtrophyBrainCohort StudiesFemaleHippocampusHumansMagnetoencephalographyMaleNeurofibrillary TanglesParietal LobeTemporal Lobealpha oscillationsAlzheimer's diseasemagnetoencephalographyneurofibrillary tangle densityneuropathologyneurophysiology

Identifiers

PMID33884753
PMCPMC8528895
OpenAlexW3156104410

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.